NCT02052648 2024-03-27Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain TumorsLumos PharmaPhase 1/2 Completed160 enrolled 21 charts
NCT04671459 2023-06-28TaRRGETProf. Franciszek Lukaszczyk Memorial Oncology CenterPhase 2 Unknown40 enrolled